• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Cardiology

Poor blood pressure control from mid- through late-life increases dementia risk

byDaniel Fisher
August 14, 2019
in Cardiology, Chronic Disease, Nephrology, Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. In this prospective cohort study, patients with midlife hypertension and either late-life hypertension or hypotension had higher risks of dementia than mid-life normotensive participants.

2. Midlife hypertension and late-life hypotension were also associated with greater risk of mild cognitive impairment.

Evidence Rating Level: 2 (Good)

Study Rundown: Though midlife hypertension has been associated with dementia in later life, it is unclear how the progression of blood pressure changes through late-life increases dementia risk. In addition, late-life hypotension has been associated with poorer cognition, but it is unclear how if this increased risk is caused by dementia pathogenesis or is instead its cause. In this prospective cohort, both late-life hypertension and hypotension combined with midlife hypertension increased the risk of dementia. In addition, midlife hypertension with late-life hypotension were also associated with greater risk of mild cognitive impairment, but not late life hypertension. It was found that younger but not older adults in this study showed increased risk if they had midlife hypertension followed by late life hypotension. White but not black participants showed a similar pattern.

Though this study suggests continually aberrant blood pressure from mid- to late-life is associated with dementia, there are many caveats and limitations of this study. First, the definition of hypertension was based on measurements of elevated blood pressure and use of anti-hypertensives with normal blood pressure, and when analyses were restricted to measured hypertension, no differences were found. In addition, there were non-significant increases in risk in those with midlife normotension and late-life aberrant blood pressure, which may still indicate increased dementia risk for poor blood pressure control in late life that was not detectable due to low statistical power. In addition, patients with worse blood pressure and cognition were more likely to drop out of the study, and so the competing risk for mortality was not accounted for in the analyses.

Click to read the study in JAMA (Journal of the American Medical Association)

RELATED REPORTS

Spousal traumatic brain injury is associated with increased mortality in the uninjured partner

Use of β3 adrenergic agonists and anticholinergics for overactive bladder are associated with similar dementia risk

Relevant Reading: Night-time home versus ambulatory blood pressure in determining target organ damage.

FDA approvedFor hypertension: Baxfendy (baxdrostat), May 15, 2026→

In-Depth [prospective cohort]: The Atherosclerosis Risk in Communities (ARIC) study recruited 4761 patients (whole cohort ~16,000; 59% women, 21% black) to be followed with blood pressure measurements at baseline, 3, 6, 9, 24, and 28 years, establishing mid-life (visits 1-4) and late-life (visits 5) blood pressures. Hypertension was defined as blood pressure >140/90 or normotensive on antihypertensives for the primary analysis and only measured >140/90 for sensitivity analysis. Hypotension was defined as systolic blood pressure <90/60. At visit 6, the participants underwent a neuropsychiatric battery of tests and dementia was defined when 3 criteria were met: Functional Activities Questionnaire greater than 5 or Clinical Dementia Rating sum of boxes greater than 3; at least 2 cognitive domain scores greater than 1.5 standard deviations below the normative mean; and an overall decline from visit 5 on the study’s cognitive battery of greater than 0.055 standard deviations per year. An expert panel confirmed each diagnosis based on the National Institute of Aging and Alzheimer’s Association criteria or the DSM-V. Mild cognitive impairment was defined as aberrations in one of the top three criteria. Dementia incidence per 100 person-years was 1.31 (CI95 1.00 to 1.72) for the midlife and late-life normotension group, 1.99 (CI95 1.69 to 2.32) for the midlife normotension and late life hypertension group, 2.83 (CI95 2.40 to 3.35) for the midlife and late-life hypertension group, 2.07 (CI95 1.68 to 2.54) for the midlife normotension and late-life hypotension group, and 4.26 (CI95 3.40-5.32) for the midlife hypertension and late-life hypotension group. Only mild-life hypertension and late-life hypotension was associated with mild cognitive impairment (OR 1.65; CI95 1.01 to 2.69). Younger patients with mid-life hypertension and late-life hypertension had a higher dementia risk than older patients, who did not have statistically elevated risk (p = 0.02). A similar pattern was seen for white patients over black patients (p = 0.02).

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dementiageriatricshypertensionhypotension
Previous Post

#VisualAbstract: Safety-Net Hospitals, Neighborhood Disadvantage, and Readmissions Under Maryland’s All-Payer Program

Next Post

The Ellipse trial: liraglutide improves glycemic control in children with type 2 diabetic on metformin

RelatedReports

Collage on head injury in adults: a calm man beside an engraved brain drawing, a bicycle helmet and a small penlight
Chronic Disease

Spousal traumatic brain injury is associated with increased mortality in the uninjured partner

November 13, 2026
Collage on urinary incontinence: an older woman smiling calmly beside an engraved bladder, a stopwatch and a teal ribbon
Chronic Disease

Use of β3 adrenergic agonists and anticholinergics for overactive bladder are associated with similar dementia risk

November 13, 2026
A profile of a human head with a visible brain, surrounded by descending bar graphs and doors leading into a fading background, suggesting themes of dementia and cognitive decline.
Weekly Rewinds

2 Minute Medicine Rewind November 9, 2026

November 11, 2026
A senior woman is depicted alongside images of a brain, a magnifying glass, a test tube, and playing cards, suggesting cognitive assessment related to dementia.
Chronic Disease

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

October 13, 2026
Next Post

The Ellipse trial: liraglutide improves glycemic control in children with type 2 diabetic on metformin

Teplizumab delays type 1 diabetes diagnosis in high risk patients

Excess body fat is a major risk factor for premature death among Hispanic patients

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Large genetic association study identifies additional Alzheimer disease risk loci and candidate pathways
  • Pelacarsen lowers lipoprotein(a) but does not reduce major cardiovascular events in patients with established cardiovascular disease
  • Durvalumab plus enfortumab vedotin was approved for perioperative treatment of muscle-invasive bladder cancer
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.